Workflow
iCAD(ICAD)
icon
Search documents
CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024
GlobeNewswire News Room· 2024-12-04 22:00
NASHUA, N.H., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Further to a release issued under the same headline on November 26, 2024 13:00 ET by iCAD, Inc., the headline and fourth paragraph have been updated to acknowledge a pending trademark application for the mark “SecondReadAI” by Lunit, Inc. The corrected release follows: iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking breast health AI technologies at ...
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024
GlobeNewswire News Room· 2024-11-26 18:00
NASHUA, N.H., Nov. 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking breast health AI technologies at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, December 1-5. Key highlights include the recent FDA-cleared ProFound Detection Version 4, clinical research presentations, and a new partnership with Cascaid Health to expand access to AI- ...
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024
GlobeNewswire News Room· 2024-11-13 21:01
NASHUA, N.H., Nov. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three and nine months ended September 30, 2024.  Third Quarter 2024 Highlights (Year over Year Performance): Total ARR was $9.3 million, up 10% year over yearTotal revenues were $4.2 million, up 4% year over yearGro ...
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
GlobeNewswire News Room· 2024-11-06 13:00
NASHUA, N.H., Nov. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today announced that Dana Brown, Chief Executive Officer, and Eric Lonnqvist, Chief Financial Officer, will attend the 15th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 19, 2024 at the Sheraton New York Times Square Hotel in New York City, New York. Mana ...
iCAD to Participate in the LD Micro Main Event XVII
Newsfile· 2024-10-16 12:00
● ● ● iCAD to Participate in the LD Micro Main Event XVII October 16, 2024 8:00 AM EDT | Source: LD Micro Nashua, New Hampshire--(Newsfile Corp. - October 16, 2024) - iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, announced today that management is participating in the LD Micro Main Event XVII on October 29-30, at the Luxe Sunset Boulevard Hotel, California. CEO Dana ...
iCAD Reports Financial Results for Second Quarter Ended June 30, 2024
GlobeNewswire News Room· 2024-08-13 20:01
NASHUA, N.H., Aug. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three and six months ended June 30, 2024. Second Quarter 2024 Highlights (Year over Year Performance): Total ARR was $9.2 million, up 7% Total revenues were $5.0 million, up 21% Gross Profit Margin was 84%, up from ...
iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography
GlobeNewswire News Room· 2024-07-29 12:00
"We are thrilled to collaborate with US Radiology to bring our advanced AI-powered mammography solutions to a broader patient base," said Dana Brown, CEO of iCAD, Inc. "This agreement aligns with our mission to create a world where cancer can't hide and ensure that all patients have access to AI's capabilities to detect cancer earlier." This strategic commercial agreement represents an advancement in breast cancer detection and patient care to advance the standard of care for women. US Radiology is one of t ...
iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024
Newsfilter· 2024-06-26 12:00
NASHUA, N.H., June 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, today announced it will highlight new research demonstrating the efficacy of its ProFound AI Risk algorithm in breast cancer risk assessment compared to traditional models at the upcoming Society for Imaging Informatics in Medicine (SIIM) Annual Meeting. The company will also highlight its recently launched ProFound Cloud, an advanced software-as-a-service (S ...
iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024
GlobeNewswire News Room· 2024-06-26 12:00
"ProFound Cloud signifies a remarkable leap forward in mammography, offering our imaging network across the Las Vegas Valley a unified and cutting-edge Breast AI technology solution," stated Angie Cosca, Chief Information Officer at Steinberg Diagnostic Medical Imaging (SDMI), an early Cloud customer. "This new innovation will enhance our operational efficiency and elevate the quality of care we provide to our patients." Attendees of SIIM 2024 are invited to visit iCAD's booth #413 to learn more about ProFo ...
iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference
GlobeNewswire News Room· 2024-06-04 12:00
NASHUA, N.H., June 04, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, announced today the Company will present at the MedInvest MedTech, AI & Digital Healthcare Conference on June 11-12, 2024 in San Francisco, CA. Dana Brown, Chief Executive Officer, and Eric Lonnqvist, Chief Financial Officer, of iCAD, Inc., will participate in one-on-one meetings with investors at t ...